staphylococcusaureus in respiratory samples from cystic … · 2019. 8. 19. · multicentre...

1
Multicentre Validation of a Chromogenic Medium for Screening of Staphylococcus aureus in Respiratory Samples from Cystic Fibrosis Patients M. Gaskin 1, A. Feroni 2 1 Hamilton Regional Laboratory Medicine Program 2 Hopital Necker – Enfants Malades Introduction Staphylococcus aureus (S. aureus) causes purulent bacterial infections, many of which can lead to serious complications resulting in significant morbidity and healthcare costs. A quarter of the population carry S. aureus asymptomatically and its early detection is vital in preventing transmission and subsequent infection. In patients with cystic fibrosis, S. aureus is one of the most commonly isolated pathogens and is associated with advanced pulmonary disease. The objective of this study was to validate the use of CHROMagarStaph aureus agar to screen for S. aureus in nasal surveillance specimens and respiratory specimens from cystic fibrosis patients. The study was carried in two hospitals: Hamilton (ON – Canada) and NECKER (Paris – France). Materials and Methods In this study a total of 200 clinical specimens were collected and seeded onto CHROMagar Staph aureus agar plates and incubated for 20 hours in an aerobic environment at 35 degrees C at which point analysis was performed. Maldi-ToF was performed on target and non-target colour colonies. Results were compared to the same samples set up on Mannitol Salt agar incubated at 35 degrees C for 20 hours. Results Of the 200 specimens tested, 81 were positive for S. aureus in both agars, an additional 9 specimens tested positive for S. aureus only on CHROMagar™ Staph aureus and 1 only on Mannitol Salt agar, for a total of 91 positive specimens. 18 specimens showed non-target colour growth, usually white or blue, on CHROMagar™ Staph aureus. These colonies were identified as Staphylococcus haemolyticus, E.faecalis. Two light pink colonies identified as Staphylococcus schleiferi and Staphylococcus epidermidis. CHROMagar™ Staph aureus agar showed a sensitivity of 99% (95%CI 0.94-1) and a specificity of 100% (95%CI 0.97-1) as compared to Mannitol Salt agar which showed a sensitivity of 89% (95%CI 0.81-0.94). Conclusion Results showed CHROMagar™ Staph aureus had a significantly greater sensitivity than Mannitol Salt in isolating S. aureus from nasal surveillance specimens and respiratory specimens from cystic fibrosis patients. S. aureus colonies were easily differentiated as mauve colour and most breakthrough growth was inhibited. Figure 5: Positive MRSA Mark Gaskin [email protected] Saturday June 9, 2018 Poster #232 Figure 2: CHROMagar™ Staph aureus Figure 1: Hamilton Microbiology Laboratory

Upload: others

Post on 07-Mar-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Staphylococcusaureus in Respiratory Samples from Cystic … · 2019. 8. 19. · Multicentre Validation of a Chromogenic Medium for Screening of Staphylococcusaureusin Respiratory

Multicentre Validation of a Chromogenic Medium for Screening of Staphylococcus aureus in Respiratory Samples from Cystic Fibrosis Patients

M. Gaskin 1, A. Feroni 2 1 Hamilton Regional Laboratory Medicine Program

2 Hopital Necker – Enfants Malades

IntroductionStaphylococcus aureus (S. aureus) causes purulent bacterial infections,many of which can lead to serious complications resulting in significantmorbidity and healthcare costs. A quarter of the population carry S.aureus asymptomatically and its early detection is vital in preventingtransmission and subsequent infection. In patients with cystic fibrosis, S.aureus is one of the most commonly isolated pathogens and isassociated with advanced pulmonary disease.The objective of this study was to validate the use of CHROMagar™Staph aureus agar to screen for S. aureus in nasal surveillancespecimens and respiratory specimens from cystic fibrosis patients. Thestudy was carried in two hospitals: Hamilton (ON – Canada) andNECKER (Paris – France).

Materials and MethodsIn this study a total of 200 clinical specimens were collected and seededonto CHROMagar Staph aureus agar plates and incubated for 20 hoursin an aerobic environment at 35 degrees C at which point analysis wasperformed. Maldi-ToF was performed on target and non-target colourcolonies. Results were compared to the same samples set up onMannitol Salt agar incubated at 35 degrees C for 20 hours.

ResultsOf the 200 specimens tested, 81 were positive for S. aureus in both agars,an additional 9 specimens tested positive for S. aureus only onCHROMagar™ Staph aureus and 1 only on Mannitol Salt agar, for a totalof 91 positive specimens. 18 specimens showed non-target colour growth,usually white or blue, on CHROMagar™ Staph aureus. These colonieswere identified as Staphylococcus haemolyticus, E.faecalis. Two light pinkcolonies identified as Staphylococcus schleiferi and Staphylococcusepidermidis. CHROMagar™ Staph aureus agar showed a sensitivity of99% (95%CI 0.94-1) and a specificity of 100% (95%CI 0.97-1) ascompared to Mannitol Salt agar which showed a sensitivity of 89% (95%CI0.81-0.94).

ConclusionResults showed CHROMagar™ Staph aureus had a significantlygreater sensitivity than Mannitol Salt in isolating S. aureus from nasalsurveillance specimens and respiratory specimens from cystic fibrosispatients. S. aureus colonies were easily differentiated as mauve colourand most breakthrough growth was inhibited.

Figure 5: Positive MRSA

Mark [email protected]

Saturday June 9, 2018Poster #232

Figure 2: CHROMagar™ Staph aureus

Figure 1: Hamilton Microbiology Laboratory